AirNexis Therapeutics
Recent Finacing
Series A
Recent Raise
$200M
AirNexis Therapeutics is a Palo Alto-based clinical-stage biotech developing novel therapeutics for chronic obstructive pulmonary disease (COPD).
Highlights
Focus Areas
Biotechnology
Health Care
Therapeutics
Recent Investors
Financials
$200M
Total Raised
1
Funding round